![Andrew Xian Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Xian Chen is the founder of SD Pharmaceuticals, Inc. (founded in 2004), Encore Therapeutics, Inc. (founded in 2006), LATITUDE Pharmaceuticals, Inc. (founded in 2003), and Cali Biosciences Co. Ltd. (founded in 2021), where he holds the title of Executive Director & Chief Scientific Officer.
He is currently the Chief Executive Officer & Director at Cali Biosciences Us LLC and a Director at Cali Shenzhen Biosciences Co. Ltd. Dr. Chen received a doctorate degree from the College of Pharmacy & Health Sciences in 1992, a graduate degree from the same institution in 1988, and an undergraduate degree from Zhejiang University School of Medicine in 1983.
| Sociétés | Poste | Début |
|---|---|---|
Cali Biosciences Co. Ltd.
 Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Engages in research, development and commercialization of drugs for perioperative anesthesia, analgesia, anti-inflammation and anti-infection | Fondateur | 17/03/2021 |
Cali Biosciences Us LLC | Directeur Général | - |
Cali Shenzhen Biosciences Co. Ltd. | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
SD Pharmaceuticals, Inc.
 SD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops reformulated treatment products for cancer and other infectious diseases | Fondateur | - |
Encore Therapeutics, Inc.
 Encore Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encore Therapeutics, Inc. is a clinical-stage pharmaceutical company that specializes in the development and commercialization of small molecule drugs for neurological disorders. The company's main focus is on the development of allosteric modulators, which are orally available drugs that target specific neurological disorders such as cough, schizophrenia, epilepsy, substance use disorder, post-stroke sensorimotor recovery, stress-related disorders including PTSD, and mild neurocognitive disorders. The company has a clinical and pre-clinical pipeline, as well as a technology platform that includes screening assays and chemistry capabilities. Encore Therapeutics, Inc. is based in Carlsbad and was founded by Andrew Xian Chen. | Fondateur | - |
LATITUDE Pharmaceuticals, Inc.
 LATITUDE Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides generic drug formulation services | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 8 |
|---|---|
SD Pharmaceuticals, Inc.
SD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops reformulated treatment products for cancer and other infectious diseases | Health Technology |
LATITUDE Pharmaceuticals, Inc.
LATITUDE Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides generic drug formulation services | Commercial Services |
College of Pharmacy & Health Sciences
 College of Pharmacy & Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zhejiang University School of Medicine
 Zhejiang University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Encore Therapeutics, Inc.
Encore Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encore Therapeutics, Inc. is a clinical-stage pharmaceutical company that specializes in the development and commercialization of small molecule drugs for neurological disorders. The company's main focus is on the development of allosteric modulators, which are orally available drugs that target specific neurological disorders such as cough, schizophrenia, epilepsy, substance use disorder, post-stroke sensorimotor recovery, stress-related disorders including PTSD, and mild neurocognitive disorders. The company has a clinical and pre-clinical pipeline, as well as a technology platform that includes screening assays and chemistry capabilities. Encore Therapeutics, Inc. is based in Carlsbad and was founded by Andrew Xian Chen. | Commercial Services |
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Engages in research, development and commercialization of drugs for perioperative anesthesia, analgesia, anti-inflammation and anti-infection | Health Technology |
Cali Shenzhen Biosciences Co. Ltd. | |
Cali Biosciences Us LLC |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
